CJC-1295 vs Ipamorelin

CJC-1295 wins for: maximizing sustained IGF-1 elevation, weekly/less frequent dosing (with DAC), longer duration of action, and driving cumulative tissue repair when paired with a GHRP.

Ipamorelin wins for: rapid, physiologic GH pulses, ultra-clean side effect profile (minimal impact on cortisol/prolactin), flexible dosing around fasted windows and workouts, and easy stacking with any GHRH analog for tailored protocols.

Pick CJC-1295 if:

• You want long-lasting IGF-1 elevation (especially with DAC) for sustained tissue repair, anti-aging, or recomposition.
• You prefer minimal injections (1–2x/week possible with DAC version).
• You're stacking with ipamorelin or another GHRP for a synergistic effect, e.g., to mimic pharma-grade HGH on a budget.
• You're after slow-burn improvements in skin quality, sleep, and joint healing over 8–12 weeks.
• You want to extend the life and effectiveness of a low-dose HGH protocol.

Pick Ipamorelin if:

• You want a fast-acting, precise GH pulse pre-workout, fasted AM, or pre-bed for maximal recovery and fat loss.
• You have a low risk tolerance—ipamorelin's selectivity means less water retention, no appetite spike, and almost no prolactin/cortisol rise.
• You're stacking with CJC-1295 no-DAC for a physiologic, pulsatile protocol (2–3x/day typical).
• You're sensitive to side effects from older GHRPs (like GHRP-6) but still want GH-axis support.
• You want an easy on-ramp compound for beginners or anyone dialing in a more complex peptide stack.